1) A proteomics approach to the cell-surface interactome using the enzyme-mediated activation of radical sources
丂 reaction.
丂 Jiang S, Kotani N, Ohnishi T, Miyagawa-Yamguchi A, Tsuda M, Yamashita R, Ishiura Y, Honke K.
丂 Proteomics. 2012 Jan;12(1):54-62. (IF: 4.505)

2) Fibroblast growth factor receptor 3 (FGFR3) associated with the CD20 antigen regulates the rituximab-induced
丂 proliferation inhibition in B-cell lymphoma cells.
丂 Kotani N, Ishiura Y, Yamashita R, Ohnishi T, Honke K.
丂 J Biol Chem. 2012 Oct 26;287(44):37109-18. (IF: 4.773)

3) Proteomic analysis of ganglioside-associated membrane molecules: substantial basis for molecular clustering.
丂 Hashimoto N, Hamamura K, Kotani N, Furukawa K, Kaneko K, Honke K, Furukawa K.
丂 Proteomics. 2012 Nov;12(21):3154-63. (IF: 4.505)

4) MRI characterization of paranodal junction failure and related spinal cord changes in mice.
丂 Takano M, Hikishima K, Fujiyoshi K, Shibata S, Yasuda A, Konomi T, Hayashi A, Baba H, Honke K, Toyama Y, Okano
丂 H, Nakamura M.
丂 PLoS One. 2012;7(12):e52904. (IF: 4.092) 丂丂丂丂丂

5) Identification of cell-surface molecular interactions under living conditions by using the enzyme-mediated activation of
丂 radical sources (EMARS) method.
丂 Honke K, Kotani N.
丂 Sensors (Basel). 2012 Nov 22;12(12):16037-45. review (IF: 1.739) 丂丂丂丂丂

6) Toward more accurate pan-specific MHC-peptide binding current methods and tools.
丂 Zhang L., Udaka K., Mamitsuka H., and Zhu S.
丂 Brief Bioinform. 2012, 13丗350-364 (IF:5.202)

7) Involvement of Akt/NF-kB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.
丂 Nakabayashi N, Shimizu K.
丂 BMC Cancer.. 2012 Oct5;12:453 (IF:3.01)

8) Stereoscopic virtual realistic surgical simulation in intracranial aneurysms.
丂 Nakabayashi H, Shimizu K.
丂 Neurology India. 2012 Mar-Apr;60(2):191-197. (IF:0.956)

9) Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration.
丂 Fukuda K, Ishida W, Uchiyama J, Rashel M, Kato S, Morita T, Muraoka A, Sumi T, Matsuzaki S, Daibata M, Fukushima
丂 A.
丂 PLoS One. 2012. 7(10):e47742. (IF: 3.730)

10) Complete genome sequences of two Helicobacter pylori bacteriophages isolated from Japanese patients.
丂 Uchiyama J, Takeuchi H, Kato S, Takemura-Uchiyama I, Ujihara T, Daibata M, Matsuzaki S.
丂 J Virol.. 2012. 86(20):11400-1. (IF 5.076) 丂

11) Analysis of deoxynucleosides in bacteriophages 冇EF24C and K and the frequency of a specific restriction site in the
丂 genomes of members of the bacteriophage subfamily Spounavirinae.
丂 Uchiyama J, Maeda Y, Takemura I, Gamoh K, Matsuzaki S, Daibata M.
丂 Arch Virol. 2012. 157(8):1587-92. (IF 2.030) 丂

12) Genetic characterization of Pseudomonas aeruginosa bacteriophage KPP10.
丂 Uchiyama J, Rashel M, Takemura I, Kato S, Ujihara T, Muraoka A, Matsuzaki S, Daibata M.
丂 Arch Virol. 2012. 157(4):733-8. (IF 2.030)

挊彂

1) 塅崅宐巕乮忋栰愳廋堦丒媑愳惓柧曇廤乯
丂怘偲寬峃偺偨傔偺柶塽妛擖栧丂丂戞10復丂偑傫偲儁僾僠僪儚僋僠儞丂p.177-198丄寶涘幮丄2012

2) 塅崅宐巕乮塱堜峆巌丒壀揷峅峎娔廋乯
丂僪儔僢僌僨儕僶儕乕僔僗僥儉偺怴揥奐俬俬丂-妀巁堛栻丒峈懱堛栻傪巟偊傞俢俢俽媄弍-丂儚僋僠儞傊偺揥奐丂4.
丂儁僾僠僪偑傫儚僋僠儞丂P.181-188丄僔乕僄儉僔乕弌斉丄2012

1) 暷崙摿嫋 US 8,288,114 B2
丂 Method for detection of compound interacting with molecule located on cell membrane.
丂 Koichi Honke, Norihiro Kotani, Naoyuki Taniguchi
丂 Oct. 16, 2012
丂 PCT/JP2008/051002

2) 儓乕儘僢僷摿嫋 EP 2,128,266 B1
丂 Method for detection of compound interacting with molecule located on cell membrane.
丂 Koichi Honke, Norihiro Kotani, Naoyuki Taniguchi
丂 Nov. 7, 2012
丂 PCT/JP2008/051002

3) 擔杮摿嫋 戞4929462崋
丂 嵶朎枌忋暘巕偲憡屳嶌梡偡傞壔崌暔偺専弌曽朄
丂 杮壠岶堦丄彫扟揟峅丄扟岥捈擵
丂 暯惉24擭2寧24擔丄摿婅2007-017667

4) 倀俽丂8324345崋
丂 乽HLA寢崌惈儁僾僠僪丄偦偺慜嬱懱丄偦傟傪僐乕僪偡傞DNA 抐曅偍傛傃慻傒姺偊儀僋僞乕乿
丂 敪柧幰丗媨愳抦栫丄塅崅宐巕丄庢摼擔丗2012.12.4

5) 擔杮崙丂摿嫋戞5067624崋
丂 乽HLA寢崌惈儁僾僠僪丄偦偺慜嬱懱丄偦傟傪僐乕僪偡傞DNA 抐曅偍傛傃慻傒姺偊儀僋僞乕乿
丂 敪柧幰丗媨愳抦栫丄塅崅宐巕丄庢摼擔丗2012.8.24

6) 擔杮崙丂摿嫋戞5116150崋
丂 乽HLA寢崌惈儁僾僠僪丄偦偺慜嬱懱丄偦傟傪僐乕僪偡傞DNA 抐曅偍傛傃慻傒姺偊儀僋僞乕乿
丂 敪柧幰丗媨愳抦栫丄塅崅宐巕丄庢摼擔丗2012.10.26

7) 2012擭12寧偵偼丄拞崙偵弌婅拞偺曻幩慄丒壔妛椕朄憹姶嵻KORTUC偑摿嫋 嵏掕偲側偭偨丅
丂 拞崙摿嫋丂弌婅斣崋丗倅俴俀侽侽俈俉侽侽係俁俁係俈丏俀 崙嵺弌婅斣崋丗俹俠俿/俰俹俀侽侽俈/侽俇俉俁俈俇
丂 敪柧偺柤徧丗曻幩慄傑偨偼峈偑傫壔妛椕朄憹姶嵻
丂 搊榐擔丗俀侽侾俁擭俀寧俇擔

8) 2013擭侾寧偵偼丄傢偑崙偱弌婅拞偺曻幩慄丒壔妛椕朄憹姶嵻KORTUC偑摿嫋嵏掕偲側偭偨丅
丂 弌婅斣崋丗摿婅俀侽侽俇亅俀俆俈俈侽俁
丂 敪柧偺柤徧丗曻幩慄傑偨偼峈偑傫壔妛椕朄憹姶嵻
丂 敪柧幰丗彫愳丂嫳峅丄庢摼擔丗俀侽侾俁擭俀寧

弌婅

1) PCT/JP2012/082573丂乽僿儖僷乕俿嵶朎桿摫惈億儕儁僾僠僪偺夵曄乿
丂 敪柧幰丗塅崅宐巕丄弌婅擔丗2012.12.14

2) 弌婅斣崋丗摿婅俀侽侾俁亅侽俀俉係侾俁
丂 敪柧偺柤徧丗僴僀僪儘僎儖傪扴懱偲偟偰夁巁壔悈慺傪彊曻偡傞庮釃撪嬊拲梡偺曻幩慄/壔妛椕朄憹姶嵻
丂 敪柧幰丗彫愳丂嫳峅丄摽淎丂巙曐丄彫揷丂廏庽丄柧娫丂椝丄墶揷丂揟榓
丂 弌婅擔丗俀侽侾俁擭俀寧侾俆擔

1) 徏嶈栁揥丒撪嶳弤暯丒撪嶳乮抾懞乯埳戙丒戝敤夒揟
丂 僶僋僥儕僆僼傽乕僕偺旜晹儕僈儞僪暘巕傪棙梡偡傞嵶嬠摨掕朄
丂 崙嵺堛栻昳尨椏丒拞娫懱揥 2012 (CPhIJAPAN2012) 丂2012擭3寧21-23擔 搶嫗

崙撪妛夛

1) 塅崅 宐巕
丂 埆惈庮釃偺儁僾僠僪柶塽椕朄丂-側傝偨偪偲揥朷-
丂 戞10夞擔杮慻怐揔崌惈妛夛丒嬤婨抧曽夛丂2012.2.11丄戝嶃巗

2) 惔悈 湪巌
丂 埆惈僌儕僆乕儅偵懳偡傞怴偨側帯椕朄傪媮傔偰
丂 戞69夞嶳宍擼恄宱奜壢崸榖夛丄2012/10/6丄嶳宍

3) 惔悈 湪巌
丂 埆惈僌儕僆乕儅偺帯椕偵懳偡傞怴偨側揥奐
丂 戞5夞惷壀導擼庮釃尋媶夛丄2012/7/13丄惷壀

4) 惔悈 湪巌
丂 憹壛偡傞崅楊幰偰傫偐傫
丂 擔杮偰傫偐傫妛夛拞崙丒巐崙抧曽夛丂巗柉岞奐島嵗丄2012/2/11丄崅抦巗

庴徿

1) 2012擭搙擔杮惗壔妛夛JB榑暥徿庴徿

2) 崙嵺娻帯椕憹姶尋媶嫤夛丄嫤夛徿丄彫愳丂嫳峅
丂 乽怴偟偄峺慺昗揑丒憹姶曻幩慄椕朄 KORTUC 偺奐敪偲偦偺椪彴墳梡乿 2013擭2寧10擔

曬摴

1) 乽堾撪姶愼傗怘拞撆丂尨場嬠傪恦懍専弌乿
丂 徏嶈 栁揥 擔宱嶻嬈怴暦 2012擭6寧25擔

2) KORTUC偺摿廤婰帠乽曻幩慄偺嵟嫮僷儚乕傪惗傒弌偡憹姶曻幩慄椕朄偺幚椡乿
丂 彫愳 嫳峅 寧姧帍乽偑傫僒億乕僩乿 2012擭12寧

偦偺懠

1) 島墘丂乽偑傫柶塽椕朄偺奐敪偲尰忬乿丂崅抦導偑傫僼僅乕儔儉丂2013.1.26
丂 塅崅宐巕

2) 擔杮憹姶曻幩慄椕朄KORTUC尋媶夛愝棫丅2012擭4寧1擔
丂 彫愳丂嫳峅 崱屻5擭娫偼丄擭偵1夞丄崅抦偱尋媶夛奐嵜梊掕丅

3) 擔杮憹姶曻幩慄椕朄KORTUC尋媶夛偺儂乕儉儁乕僕姰惉丅 2012擭9寧
丂 彫愳丂嫳峅

1) Aldosterone Stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and
丂 connective tissue growth factor in rat mesangial cells via serum-and glucocorticoid-inducible protein kinase-1.
丂 Terada Y, Ueda S, Hamada K, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Kagawa T, Horino T, Takao T.
丂 Clin Exp Nephrol. 2012, 16:81-88(IF: 1.374)

2) Upregulation of HNF-1兝 during experimental acute kidney injury palys a crucial role in renal tuble regeneration.
丂 Ogata K,丂Shimamura丂Y丆丂Hamada丂K,丂Hisa M,丂Bun M丆Okada丂N, Inoue丂K, Taniguchi Y, Ishinara M, Kagawa
丂 T, Horino T, Fujimoto S, Terada Y.
丂 Am J Physiol Reneal Physiol. 2012, 303:F689-699 (IF:3.682)

3) Images in clinical Medicine. Pencil-Core Granuloma
丂 Taguchi T, Terada Y.
丂 The New England Journal of Medicine. 2012, 366: 2408 (IF:53.298)

4) Remarkable Cystic Expansion of Microprolactinoma Causing Diabetes Insipidus during Pregnancy.
丂 Amano E, Nishiyama M, Iwasaki Y, Matsushima S, Oguri H, Fukuhara N,Nishioka H, Yamada S, Inoshita N, Fukaya T,
丂 Terada Y.
丂 J Clin Endocrinol Metab. August 2012, 97(8):2575-2576 (IF:5.967)

5) Serum levels of soluble secreted 兛-Klotho are decreased in the early stages of chronic kindney disease,making it a
丂 probable novel biomarker for early diagnosis.
丂 Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K,
丂 Yamanaka S, Sugiura T, Terada Y.
丂 Clin Exp Nephrol. 2012, 16丗722-729 (IF:1.374)

6) Frequency of enthesitis in apparently healthy Japanese subjects detected by (18)F FDG-PET/CT.
丂 Taniguchi Y, Kumon Y, Ohnishi T ,Nogami M, Tani T, Ogawa Y, Sugiura T, Terada Y.
丂 Mod Rheumatol. 2012, 22:939-941 (IF:1.577)

7) Liver X receptor兛is involved in the transcriptional regulation of the 6-phosphofructo-2- kinase/fructose-2, 6-
丂 disphosphatase gene.
丂 Zhao LF, Iwasaki Y, Nishiyama M, Taguchi T, Tsugita M, Okazaki M, Nakayama S, Kambayashi M, Fujimoto S,
丂 Hashimoto K, Murao K, Terada Y.
丂 Diabetes 2012 May, 61(5):1062-71丂(IF:8.286)

8) Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes
丂 Taniguchi Y, Pippin JW, Hagmann H, Krofft RD, Chang AM, Zhang J, Terada Y, Brinkkoetter P, Shankland SJ.
丂 Am J physiol Renal Physiol. 2012, 302(9):F1161-71 (IF:3.682)

9) Plasma dehydroepiandrosterone sulphate and insulin-like growth factor 1 levels in obstructive sleep apnoea
丂 syndrome.
丂 Makino丂S, Fujiwara M, Handa H, Fujie T, Aoki Y, Hashimoto K, Terada Y, Sugimoto T.
丂 Clin Endocrinol. 2012, 76: 593-601 (IF:3.168)

10) Renal disease int the elderly and the very elderly Japanese:analysis of the Japan Renal Biopsy Registry(J-RBR).
丂 Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, Makino H,Watanabe T, Saito T, Kiyohara Y, Nishi
丂 S, Iida H, Morozumi K, Fukatsu A, Sasaki T, Tsuruya K, Khoda Y, Higuchi M, Kiyomoto H, Goto S, Hattori M, Hataya H,
丂 Kagami S, Yoshikawa Y, Fukasawa Y, Ueda Y, Kitamura H,Shimizu A, Oka K, N nakagawa, Ito T, Uchida S, Furuichi K,
丂 Nakaya I,Umemura S, Hiromura K, Yoshimura M, Hirawa N,Shigematsu T, Fukagawa M, Hiramatsu M,Terada
丂 Y,Uemura O, Kagawa T, Matsunaga A, Kuroki A, Mori Y, Mitsuiki K, Yoshida H.
丂 Clin Exp Nephrol. 2012, 16丗903-920 (IF:1.374)

11) Effective perioperative management of multiple endocrine neoplasia type1-associated insulinomas.
丂 Hanazaki K, Sakurai A, Munekage M, Okabayashi T, Imamura M.
丂 Arch Surg. 2012:147(11)Nov:991-992 (IF 4.100)

12) Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy:
丂 tight glycemic control may be justified in order to avoid brittle diabetes.
丂 Hanazaki K, Yatabe T, Kobayashi M, Tsukamoto Y, Kinoshita Y, Munekage M, Kitagawa H.
丂 Biomed Mater Eng. 2013;23(1-2):109-16. doi: 10.3233/BME-120736. (IF 1.087)

13) Surgery for gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1.
丂 Hanazaki K, Sakurai A, Munekage M, Ichikawa K, Namikawa T, Okabayashi T, Imamura M.
丂 Surg Today. 2013 Mar;43(3):229-36.doi: 10.1007/s00595-012-0376-5. Epub 2012 Oct 19. Review. (IF: 1.224)

14) Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicenter database.
丂 Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T,
丂 Horiuchi K, Miyauchi A, Imamura M; MEN Consorium of Japan, Fukushima T, Hanazaki K, Hirakawa S, Igarashi T,
丂 Iwatani T, Kammori M, Katabami T, Katai M, Kikumori T, Kiribayashi K, Koizumi S, Midorikawa S, Miyabe R,
丂 Munekage M, Ozawa A, Shimizu K, Sugitani I, Takeyama H, Yamazaki M.
丂 Clin Endocrinol (Oxf). 2012 Apr 76(4): 533-539. (IF: 3.168)

15) Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after
丂 pancreatic resection.
丂
丂 Hanazaki K.
丂 World J Gastroenterol. 2012: 18(29)Aug:3787-3789. Epub 2012 Aug 7 (IF 2.547)

16) The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection.
丂
丂 Tsujii S, Okabayashi T, Shiga M, Takezaki Y, Sugimoto T, Kobayashi M, Hanazaki K.
丂 World J Surg. 2012: 36(5)May:1122-1127. Epub 2012 Feb 25 (IF 2.228)

17) A proteomics approach to the cell-surface interactome using the enzyme-mediated activation of radical sources
丂 reaction.
丂
丂 Jiang S, Kotani N, Ohnishi T, Miyagawa-Yamguchi A, Tsuda M, Yamashita R, Ishiura Y, Honke K.
丂 Proteomics. 2012 Jan;12(1):54-62. (IF:4.505)

18) Superoxide dismutase activity of Helicobacter pylori per se from 158 clinical isolates and the characteristics.
丂
丂 Morishita K, Takeuchi H, Morimoto N, Shimamura T, Kadota Y, Tsuda M, Taniguchi T, Ukeda H, Yamamoto T, Sugiura
丂 T.
丂 Microbiol Immunol. 2012 Apr;56(4):262-72. (IF:1.304)

19) High expression of nuclear factor 90 (NF90) leads to mitochondrial degradation in skeletal and cardiac muscles.
丂
丂 Higuchi T, Sakamoto S, Kakinuma Y, Kai S, Yagyu K, Todaka H, Chi E, Okada S, Ujihara T, Morisawa K, Ono M,
丂 Sugiyama Y, Ishida W, Fukushima A, Tsuda M, Agata Y, Taniguchi T.
丂 PLoS One. 2012;7(8):e43340. (IF: 4.092)

20) Molecular anatomy of tunicate senescence: reversible function of mitochondrial and nuclear genes associated with
丂 budding cycles.
丂
丂 Kawamura K, Kitamura S, Sekida S, Tsuda M, Sunanaga T.
丂 Development. 2012 Nov;139(21):4083-93. (IF: 6.596)

21) Transcriptional elongation factor elongin A regulates retinoic acid-induced gene expression during neuronal
丂 differentiation.
丂
丂 Yasukawa T, Bhatt S, Takeuchi T, Kawauchi J, Takahashi H, Tsutsui A, Muraoka T, Inoue M, Tsuda M,
丂 Kitajima S, Conaway RC, Conaway JW, Trainor PA, Aso T.
丂 Cell Rep. 2012 Nov 29;2(5):1129-36

22) A protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei.
丂
丂 Hitsuda T, Michiue H, Kitamatsu M, Fujimura A, Wang F, Yamamoto T, Han XJ, Tazawa H, Uneda A, Ohmori I, Nishiki
丂 T, Tomizawa K, Matsui H.
丂 Biomaterials. 2012 Jun;33(18):4665-72. (IF:7.404)

23) The therapeutic potential of human umbilical cord blood transplantation for neonatal hypoxic-ischemic brain injury
丂 and ischemic stroke.
丂
丂 Wang F, Maeda N, Yasuhara T, Kameda M, Tsuru E, Yamashita T, Shen Y, Tsuda M, Date I, Sagara Y.
丂 Acta Med Okayama. 2012;66(6):429-34. (IF:0.657)

1) 愇尨惓峴丄摗巬姴栫丄帥揷揟惗
丂 擜嵶娗忈奞偲嵞惗偺暘巕婡彉
丂 Annual Review恡憻2012丗127-132丆2012

2) 搰懞朏巕丄郷揷壚庻丄嬤峕孭巕丄弿曽岻擇丄師揷惤丄崄愳嫓丄帥揷揟惗 丂
丂 僩儖僶僾僞儞傪暪梡偡傞偙偲偱怱晄慡徢岓傪掓偟偨旝彮曄壔宆僱僼儘乕僛徢岓孮偵偍偄偰尷奜鄅夁偵傛傞彍悈傪夞旔偟摼偨堦椺 丂
丂 堛栻僕儍乕僫儖2寧崋Vol.48 噦2丗164-166丆2012

3) 搶瀶柧擔崄丄嶳嶈捈恗丄嶁杮抦戙丄揷岥悞暥丄帥揷揟惗丄搚嫃媊揟 丂
丂 嵍幒旍戝傪敽偆庒擭惈崅寣埑偐傜暃恡惈Cushing徢岓孮偺恌抐偵帄偭偨侾椺 丂
丂 崅抦巗堛帍17乮侾乯丗176-181丆2012

4) 弿曽岻擇丄徏杮棾婫丄郷揷壚庻丄扟岥媊揟丄帥揷揟惗 丂
丂 AKI偺昦懺丄娗棟偲梊屻 丂
丂 堛栻僕儍乕僫儖11寧崋Vol.48 噦11丗164-88012

5) 愇嫶埢巕丄堜忋崃棟丄崅揷峗巎丄摗杮怴暯丄帥揷揟惗 丂
丂 摦柆峝壔徢偺怴偟偄恌抐 丂
丂 帯椕昗揑丄戞1復43-52丏儊僨傿僇儖儗價儏乕幮丂2012

6) 堜忋峢曘丄崄愳嫓丄帥揷揟惗 丂
丂 AKI偺娗棟Q仌A丂-媬媫丒廤拞帯椕偺偨傔偺幙栤237- 丂
丂 媬媫丒廤拞帯椕Vol.24丂No.3丒4丂475-480丂2012

7) 帥揷揟惗 丂
丂 巺媴懱恡墛 昦婜丒昦懺丒廳徢搙偐傜傒偨幘姵暿娕岇夁掱+昦懺娭楢恾丂戞擇斉 丂
丂 807-811丂堛妛彂堾丂2012

8) 弿曽岻擇丄帥揷揟惗 丂
丂 AKI偺梊屻偲嵞惗椕朄丂AKI媫惈恡忈奞偺偡傋偰婎慴偐傜椪彴傑偱偺嵟怴抦尒Part嘥 丂
丂 椪彴憤榑丂86-92丏撿峕摪丂2012

9) 堜忋峢曘丄帥揷揟惗 丂
丂 楢実偟偰恌傞恡幘姵丂僞僀儉儕乕側徯夘偐傜姵幰儅僱僕儊儞僩傑偱丂
丂 恡幘姵偺娪暿偲儅僱僕儊儞僩偺梫揰丂栻嵻惈恡忈奞傪媈偭偨傜 丂
丂 medicina Vol.49 no.12 丂1958-1962丂 2012

10) 崄愳嫓丄帥揷揟惗 丂
丂 儊僒儞僊僂儉憹怋惈巺媴懱恡墛[IgA恡徢, non-IgA恡徢] 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯噦17丗60-61丆2012

11) 弿曽岻擇丄搰懞朏巕丄堜忋峢曘丄崄愳嫓丄帥揷揟惗 丂
丂 娗撪憹怋惈巺媴懱恡墛 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯丂噦17丗74-75丆2012

12) 堜忋峢曘丄搰懞朏巕丄弿曽岻擇丄帥揷揟惗 丂丂丂丂丂丂丂
丂 僇儕僂儉憆幐惈恡徢 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯丂噦17丗811丆2012

13) 搰懞朏巕丄帥揷揟惗 丂丂丂丂丂丂丂
丂 僫僩儕僂儉憆幐惈恡徢 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯丂噦17丗821丆2012

14) 搰懞朏巕丄嶰戭怶丄搾愺寬巌丄壀椦峅婤丄帥揷揟惗 丂丂丂丂丂丂丂
丂 枬惈恡憻昦懳嶔偲抧堟楢実 丂
丂 擔杮撪壢妛夛嶨帍101丗1266-1271丆2012

15) 愇尨惓峴丄帥揷揟惗 丂丂丂丂丂丂丂
丂 乻愭恑揑帯椕乼AKI偵偍偗傞嵞惗堛椕偺壜擻惈 丂
丂 撪壢丂Vol.110 No.3丗449-451丆2012

16) 師揷惤丄帥揷揟惗 丂丂丂丂丂丂丂
丂 崅寣埑偵敽偆懱塼挷惍儂儖儌儞偺曄壔偲偦偺堄媊 丂
丂 [摿廤]崅寣埑偲懱塼娗棟 儊僨傿僇儖儗價儏乕幮丂Fluid Management Renaissance Vol.2 No.4 27(347-352) 2012

17) 堜忋峢曘丄帥揷揟惗 丂丂丂丂丂丂丂
丂 栻嵻惈恡忈奞傪媈偭偨傜 丂
丂 堛妛彂堾丂medicina 11 Vol.49 No.12丗1958-1962 2012-11

18) 師揷惤丄崄愳嫓丄堜忋峢曘丄帥揷揟惗丄娾�睉讗� 丂丂丂丂丂丂丂
丂 僒儖僐僀僪乕僔僗偲恡忈奞 丂
丂 暿嶜擔杮椪喱幮丂恡憻徢岓孮乮戞2斉乯噦18丗739-743丆2012

19) 壴�睒a峅丄彫愳摴梇 丂丂丂丂丂丂丂
丂 嘦奜壢椞堟丂11奜壢廃弍婜偺寣摐娗棟偺堄媊 丂
丂 椪彴偵栶棫偮嵟怴寣摐娗棟儅僯儏傾儖 (彫愳摴梇丒恴朘朚晇丒栧榚岶娔廋丄壴�睒a峅曇廤) pp89-95 堛妛恾彂弌斉 2012

20) 壴�睒a峅 丂丂丂丂丂丂丂
丂 娞娻娞愗彍偵偍偗傞暘婒嵔傾儈僲巁梓棻惢嵻搳梌偺堄媊 丂
丂 娞偑傫丒娞峝曄偵懳偡傞塰梴椕朄偺怴帪戙 (巗揷棽暥丒暯栰崕帯娔廋丒曇廤) pp69-72傾乕僋儊僨傿傾 2012

21) 廆宨奊棦丄抾�睏R壚丄壴�睒a峅 丂丂丂丂丂丂丂
丂儅僌僱僔僂儉乣惗懱挷愡丒栻嵻偲偟偰偺廳梫惈乣丂摐擜昦偵偍偗傞儅僌僱僔僂儉戙幱堎忢偲偦偺帯椕堄媊 丂
丂Clin Calcium 22(8)8寧:1235-1242

22) 壴�睒a峅 丂丂丂丂丂丂丂
丂恖岺鋁憻傪梡偄偨廃弍婜偺寣摐惓忢壔 丂
丂椪彴塰梴 121(6)11寧:714-716

1) Hanazaki K, Munekage M, Ichikawa K, Kitagawa H, Tsukamoto Y, Okabayashi T
丂 Intensive insulin therapy using an artificial pancreas with closed-loop system: No hypoglycemia and improvement
丂 of surgical site infection.
丂 5th International Conference Advanced Technologies Treatments Diabetes :2012 Barcelona, Spain

2) Takezaki Y, Okabayashi T, Munekage M, Ichikawa K, Hanazaki K
丂 Nafamostat mesilate, an inhibitor of nuclear factor-kappa B, limits oncogenic properties of pancreas carcinoma cells
丂 International Symposium Pancreas Cancer : 2012 Kyoto

3) Hanazaki K, Munekage M, Yatabe T, Ichikawa K, Kitagawa H, Tsukamoto Y, Kinoshita Y, Namikawa T, Takezaki Y,
丂 Okabayashi T
丂 Perioperative intensive insulin therapy using an artificial pancreas with closed-loop system in hepatectomized patients
丂 12th Annual Diabetes Technology Meeting : 2012 Bethesda, USA

崙撪妛夛

1) 帥揷揟惗
丂 CKD懳嶔偺崅抦導偱偺庢傝慻傒乗戝妛昦堾丄堛巘夛丄婎姴昦堾丄峴惌偺僱僢僩儚乕僋偲僨乕僞儀乕僗嶌惉乗
丂 戞42夞擔杮恡憻妛夛惣晹妛弍戝夛丄媂栰榩巗丄2012

2) 愇尨惓峴丄帥揷揟惗
丂 Mitophagy 偲丂Autophagy偺挷愡婡彉
丂 戞55夞丂擔杮恡憻妛夛妛弍憤夛丄墶昹丄2012

3) 堜忋峢曘丄崄愳嫓丄帥揷揟惗
丂 恡憻昦偵偍偗傞僆乕僩僼傽僕乕偺堄媊
丂 戞55夞丂擔杮恡憻妛夛妛弍憤夛丄墶昹丄2012

4) 壴�睒a峅
丂 ERAS傪栚巜偟偨恖岺鋁憻傪梡偄偨奜壢廃弍婜寣摐娗棟
丂 戞112夞擔杮奜壢妛夛掕婜妛弍廤夛丄(儔儞僠儑儞僙儈僫乕)丄2012擭4寧丄暉壀

5) 廆宨嫥嵠丄暉塱夑巕丄壀椦梇戝丄栴揷晹抭徍丄杒愳攷擵丄抾�睏R壚丄捤杮梇婱丄壴�睒a峅
丂 娞嫊寣嵞娏棳屻偺媫寖側寣摐忋徃偵娭傢傞場巕偵娭偡傞専摙
丂 戞112夞擔杮奜壢妛夛掕婜妛弍廤夛丄2012擭4寧丄暉壀

6) 壴�睒a峅丄杒愳攷擵丄娾晹丂弮丄廆宨嫥嵠丄巗愳尗屷丄抾�睏R壚丄壀椦梇戝丄壀杮丂寬丄暲愳丂搘丄彫椦摴栫
丂 戝寶拞搾偺ADME偐傜傒偨徚壔娗婡擻堎忢懳嶔
丂 戞67夞擔杮徚壔婍奜壢妛夛掕婜妛弍憤夛丄2012擭7寧丄晉嶳

7) 抾�睏R壚丄廆宨嫥嵠丄嬥巕梞暯丄戝嶳丂憦丄敀悾崄巕丄擇懞梇夘丄壴�睒a峅
丂 娞憻娻儔僢僩儌僥儖傪梡偄偨僇儖儁儕僠僪偺墛徢惈僒僀僩僇僀儞偍傛傃娞婡擻曐岇嶌梡偵媦傏偡塭嬁偵偮偄偰偺専摙
丂 戞19夞奜壢怤廝偲僒僀僩僇僀儞尋媶夛丄2012擭12寧丄恄屗

戞55夞擔杮恡憻妛夛妛弍憤夛乽桪廏墘戣徿乿 丂丂丂丂
壀揷撧寧
乽Six2亅GDNF乮glial cell-derived neurotrophic growth factor乯宯偼媫惈恡忈奞偱偺擜嵶娗嵞惗偲宍惉偵廳梫側栶妱傪壥偨偡乿

1) 捗揷夒擵
丂 鋊懷寣拞偵枩擻嵶朎乮懡擻惈姴嵶朎乯傪媮傔偰
丂 戞72婜丂崅抦巗柉偺戝妛丄 崅抦丄 12/18丄2012

2) 嶳壓棾岾
丂 惗懱暘巕偺弌夛偄偲暿傟
丂 戞72婜丂崅抦巗柉偺戝妛丄 崅抦丄 11/27丄2012

1) Algorithm for estimation of thyroid gland size in ultrasonography images for extracting abnormal thyroid in medical
丂 practice.
丂 Hatakeyama, Y. , Kataoka, H., Nakajima, N., Watabe, T., Okuhara, Y.
丂 Journal of Advanced Computational Intelligence and Intelligent Informatics.. 2012 16(1)87-93丂(IF柍偟)

2) Hepatocyte destruction with enhanced collagen synthesis: characteristic feature of chronic hepatitis C patients on
丂 haemodialysis.
丂 M. Ue, N. Ikebe, K. Munekage, T. Ochi, A. Hirose, H. Kataoka, S. Fujimoto, K. Kikuchi, Y. Okuhara, M. Ono and T.
丂 Saibara.
丂 Journal of Viral Hepatitis. Article first published online : 11 DEC 2012, DOI: 10.1111/jvh.12031 (IF 4.088)

3) Prognostic Significance of Smoking in Patients with Acute Ischemic Stroke within 3 Months of Onset.
丂 Kumagai N, Origasa H, Nagao T, Takekawa H, Okuhara Y, Yamaguchi T
丂 J Stroke Cerebrovasc Dis. 2013 Aug;22(6):792-8. Epub 2012 May 24. (IF 1.68)

4) Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase
丂 levels.
丂 Yoneda M, Imajo K, Eguchi Y, Fujii H, Sumida Y, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Aoki N, Sata M, Kanemasa
丂 K, Kohgo Y, Saibara T, Chayama K, Itoh Y, Yoshikawa T, Anzai K, Fujimoto K, Okanoue T, Nakajima A; Japan Study
丂 Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
丂 J Gastroenterol. 2013 Sep;48(9):1051-60. Epub 2012 Nov 27. (IF 4.16)

5) Prognosis of autoimmune hepatitis showing acute presentation.
丂 Yamamoto K, Miyake Y, Ohira H, Suzuki Y, Zeniya M, Onji M, Tsubouchi H; the Intractable Liver and Biliary Diseases
丂 Study Group of Japan.
丂 Hepatol Res. 2013 Jun;43(6):630-8. doi: 10.1111/j.1872-034X.2012.01109.x. Epub 2012 Oct 22.(IF 2.20)

6) Abnormality in expression levels of gluconeogenesis-related genes by high-dose supplementation with pyridoxamine
丂 in mice.
丂 Thi Viet Do H, Toda K, Saibara T, Yagi T.
丂 Int J Vitam Nutr Res. 2012 Feb;82(1):34-40. doi: 10.1024/0300-9831/a000092. (IF 0.88)

7) BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
丂 Taniuchi K, Yokotani K, Saibara T.
丂 Neoplasia. 2012 May;14(5):440-50. (IF 5.95)

8) Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver
丂 disease in Japanese.
丂 Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, Yasui K, Saibara T, Hashimoto E,
丂 Kawanaka M, Watanabe S, Kawata S, Imai Y, Kokubo M, Shima T, Park H, Tanaka H, Tajima K, Yamada R, Matsuda
丂 F; Takeshi Okanoue, Japan Study Group of Nonalcoholic Fatty Liver Disease.
丂 PLoS One. 2012;7(6):e38322. doi: 10.1371/journal.pone.0038322. Epub 2012 Jun 14. (IF 4.09)

9) 17兝-Estradiol is critical for the preovulatory induction of prostaglandin E(2) synthesis in mice.
丂 Toda K, Ono M, Yuhki K, Ushikubi F, Saibara T.
丂 Mol Cell Endocrinol. 2012 Oct 15;362(1-2):176-82. doi: 10.1016/j.mce.2012.06.006. Epub 2012 Jun 17. (IF 4.19)

10) BART inhibits pancreatic cancer cell invasion by PKC兛 inactivation through binding to ANX7.
丂 Taniuchi K, Yokotani K, Saibara T.
丂 PLoS One. 2012;7(4):e35674. doi: 10.1371/journal.pone.0035674. Epub 2012 Apr 19. (IF 4.09)

11) Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.
丂 Yasui K, Hashimoto E, Tokushige K, Koike K, Shima T, Kanbara Y, Saibara T, Uto H, Takami S, Kawanaka M,
丂 Komorizono Y, Okanoue T; The Japan NASH Study Group.
丂 Hepatol Res. 2012 Aug;42(8):767-773. doi: 10.1111/j.1872-034X.2012.00986.x. Epub 2012 Apr 4. (IF 2.20)

12) High expression of nuclear factor 90 (NF90) leads to mitochondrial degradation in skeletal and cardiac muscles.
丂 Higuchi T, Sakamoto S, Kakinuma Y, Kai S, Yagyu K, Todaka H, Chi E, Okada S, Ujihara T, Morisawa K, Ono M,
丂 Sugiyama Y, Ishida W, Fukushima A, Tsuda M, Agata Y, Taniguchi T.
丂 PLoS One. 2012;7(8):e43340. doi: 10.1371/journal.pone.0043340. Epub 2012 Aug 17. (IF 4.09)

13) Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009
丂 to 2010 in Japan: a multicenter large retrospective study.
丂 Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, Chayama K, Saibara T; JSG-NAFLD.
丂 J Gastroenterol. 2012 May;47(5):586-95. doi: 10.1007/s00535-012-0533-z. Epub 2012 Feb 11. (IF 4.16)

14) Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non
丂 -alcoholic fatty liver disease.
丂 Masuda K, Ono M, Fukumoto M, Hirose A, Munekage K, Ochi T, Okamoto N, Akagi N, Ogawa Y, Saibara T.
丂 Hepatol Res. 2012 Mar;42(3):273-9. doi: 10.1111/j.1872-034X.2011.00923.x. Epub 2012 Jan 18. (IF 2.20)

15) Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
丂 Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K,
丂 Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver
丂 Disease (JSG-NAFLD)
丂 BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2. (IF2.42 )

16) Impact of ovarian sex steroids on ovulation and ovulatory gene induction in aromatase-null mice.
丂 Toda K, Hayashi Y, Ono M, Saibara T.
丂 Endocrinology. 2012 Jan;153(1):386-94. (IF 4.75)

17) Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis?
丂 Ono M, Saibara T.
丂 J Gastroenterol Hepatol. 2012 Apr;27(4):622-4. doi: 10.1111/j.1440-1746.2012.07084.x. (IF 2.87)

18) Is rosuvastatin effective for non-alcoholic steatohepatitis with dyslipidemia?
丂 Ono M.
丂 Hepatol Res. 2012 Nov;42(11):1055-7. doi: 10.1111/j.1872-034X.2012.01052.x.

1) 惣尨棙帯丄彫栰惓暥
丂丂丂丂丂丂丂
丂 8丂旕傾儖僐乕儖惈帀朾惈娞幘姵 丂
丂 椦婭晇丒擔斾婭暥丒忋惣婭晇丒壓悾愳揙曇丄Annual Review 2012 徚壔婍丄139-144丄拞奜堛妛幮丄搶嫗丄2012

2) 彫栰惓暥丄惣尨棙帯
丂丂丂丂丂丂丂
丂 NASH/NAFLD偺塽妛丄 壀忋晲曇丂徢椺偵妛傇 丂
丂 NASH/NAFLD偺恌抐偲帯椕丄 2-6丄 恌抐偲帯椕幮丄 搶嫗丄2012

3) 惣尨棙帯
丂丂丂丂丂丂丂
丂 旕傾儖僐乕儖惈帀朾娞墛偱偼姤摦柆幘姵偺儕僗僋偑崅偔側傞偺偱偡偐丠 丂
丂 嶳娸徆堦曇廤丂摐擜昦偲寣娗崌暪徢偵娭偡傞100偺幙栤丄128-129丄儊僨傿僇儖價儏乕幮丄搶嫗丄2012

4) 惣尨棙帯丄塇幠婎丄彫栰惓暥
丂丂丂丂丂丂丂
丂 嵟怴椪彴摐擜昦妛丂壓 丂
丂 165-169暸丄擔杮椪彴幮丄搶嫗丄2012

5) 惣尨棙帯丄彫栰惓暥
丂丂丂丂丂丂丂
丂 徚壔婍幘姵偺恌抐婎弨丄昦宆暘椶丄廳徢搙偺梡偄曽 丂
丂 199-203暸丄擔杮儊僨傿僇儖僙儞僞乕丄搶嫗丄2012

6) 惣尨棙帯丄彫栰惓暥
丂丂丂丂丂丂丂
丂 傾儖僐乕儖惈帀朾惈娞幘姵丂徚壔婍幘姵恌椕偺偡傋偰 丂
丂 愓尒桾懠曇 271-273暸丄擔杮堛巘夛丄搶嫗丄2012

7) 惣尨棙帯丄彫栰惓暥
丂丂丂丂丂丂丂
丂 帀朾娞丂怴椪彴塰梴妛 丂
丂 攏応拤梇丄嶳忛梇堦榊曇 569-574暸丄堛妛彂堾丄搶嫗丄2012

8) 惣尨棙帯丄彫栰惓暥
丂丂丂丂丂丂丂
丂 NAFLD丂徚壔婍幘姵丂嵟怴偺帯椕 丂
丂 悰栰寬懢榊丄忋惣婭晇丄堜夢摴晇曇丂328-331暸丄撿峕摪丄搶嫗丄2012

弌婅

1) 弌婅斣崋丗摿婅2012-250498崋 丂丂丂丂丂
丂 敪柧偺柤徧丗俠俛俠僗僉儍僢僞僌儔儉傪梡偄偨恌抐巟墖憰抲 丂丂丂丂丂
丂 敪柧幰丗曅壀峗枻丄敥嶳朙丄墱尨媊曐丄悪塝揘楴
丂 弌婅擔丗2012擭11寧14擔

1) 曅壀峗枻
丂丂丂丂丂丂丂
丂 POSTER AWARD 丂
丂 乽CBC cell distribution data yield remarkable laboratory diagnostic characteristics乿 丂丂丂丂丂丂丂
丂 乮CBC寣媴棻搙僨乕僞偵愽傓堄奜側専嵏恌抐摿惈偺敪尒乯 丂丂丂丂丂丂丂
丂 The 8th International Conference of Clinical Laboratory Automation 丂丂丂丂丂丂丂
丂 乮2012擭4寧12擔丄Seoul乯

2) 瀢奯岹旤乮廋巑壽掱堛壢妛愱峌忣曬堛壢妛僐乕僗乮愭抂堛椕妛悇恑僙儞僞乕忣曬堛椕晹栧乯妛惗乯
丂丂丂丂丂丂丂
丂 擔杮堛椕忣曬妛夛庒庤彠椼徿 丂
丂 乽戞31夞堛椕忣曬妛楢崌戝夛乿偱峴偭偨敪昞乽NSAIDs偺COX慖戰偺桳柍偵傛傞媫惈恡婡擻忈奞偺儕僗僋偵娭偡傞専摙丒昡壙乿
丂 偵懳偟丄6寧1擔偺乽戞16夞擔杮堛椕忣曬妛夛弔婫妛弍戝夛乿偱昞彶偝傟偨丅

3) 扟撪宐夘丂乮崅抦戝妛栻棟妛乯
丂丂丂丂丂丂丂
丂 暯惉俀係擭搙鋁憻昦尋媶彠椼徿丂岞塿嵿抍朄恖擔杮鋁憻昦尋媶嵿抍 丂
丂 鋁娻偵懳偡傞儁僾僠僪儚僋僠儞椕朄偺暘巕昗揑偱偁傞kinesin family member20A(KIF20A)偺鋁娻怹弫丒揮堏槾恑傊偺娭梌

1) What is a common factor in different areas? : The case of depression among caregivers of the frail elderly in Sapporo
丂 and Kochi, Japan.
丂 Oura A, Mori M, Yasuda N, Miyano I, Izumi H, Washio M.
丂 Geriatr Gerontol Int. 2012 Apr;12(2):230-7. doi: 10.1111/j.1447-0594.2011.00754.x. Epub 2011 Oct 17. (IF 2.164乯

2) Propolis Inhalation Reduces Allergic Airway Inflammation in Dermatophagoides farinae -treated Mice.
丂 Hirota R, Ngatu NR, Nakamura H, Suganuma N.
丂 J Prev Med. 2012;7(3):103-10. (IF=No data)

3) The new materials for the filter to prevent allergic asthma caused by diesel exhaust: amorphous iron hydroxide and
丂 activated carbon.
丂 Hirota R, Kang Y, Nakamura H, Uesaka S, Sakurai K, Narongpon D, Ngatu NR, Suganuma N.
丂 J Prev Med. 2012;7(3):95-102. (IF=No data)

4) Development of a guideline on reading CT images of malignant pleural mesothelioma and selection of the reference
丂 CT films.
丂 Zhou H, Tamura T, Kusaka Y, Suganuma N, Subhannachart P, Vijitsanguan C, Noisiri W, Hering KG, Akira M, Itoh H,
丂 Arakawa H, Ishikawa Y, Kumagai S, Kurumatani N.
丂 Eur J Radiol. 2012 Dec;81(12):4203-10. doi: 10.1016/j.ejrad.2012.08.008. Epub 2012 Sep 13. (IF2.606)

5) Anti-allergic effects of Vernonia amygdalina leaf extracts in hapten-induced atopic dermatitis-like disease in mice.
丂 Ngatu NR, Okajima MK, Yokogawa M, Hirota R, Takaishi M, Eitoku M, Muzembo BA, Sabah AB, Saruta T, Miyamura M,
丂 Kaneko T, Sano S, Suganuma N.
丂 Allergol Int. 2012 Dec;61(4):597-607. doi: 10.2332/allergolint.11-OA-0393. Epub 2012 Aug 25. (IF=No data)

6) Fundamental study of detection of muscle hypertrophy-oriented gene doping by myostatin knock down using RNA
丂 interference.
丂 Takemasa T, Yakushiji N, Kikuchi DM, Deocaris C, Widodo, Machida M, Kiyosawa H.
丂 J Sport Sci Med. 2012 Jun;11(2): 294-303. (IF=0.754)

7)Possible involvement of microRNA-21 in skeletal muscle hypertrophy.
丂 Takemasa T, Abe Y, Kumagai C, Kiyosawa H.
丂 Adv Exerc Sports Physiol.. 2012 Jun;18(1): 5-15. (IF=No data)

8) Reduction of ribosome biogenesis with activation of the mTOR pathway in denervated atrophic muscle.
丂 Machida M, Takeda K, Yokono H, Ikemune S, Taniguchi Y, Kiyosawa H, Takemasa T.
丂 J Cell Physiol.2012 Apr;227(4):1569-76. doi: 10.1002/jcp.22871. (IF=3.874)

9) Anti-inflammatory effects of sacran, a novel polysaccharide from Aphanothece sacrum, on 2,4,6-trinitrochlorobenzene
丂 -induced allergic dermatitis in vivo.
丂 Ngatu, N. R., M. K. Okajima, M. Yokogawa, R. Hirota, M. Eitoku, B. A. Muzembo, N. Dumavibhat, M. Takaishi, S.
丂 Sano, T. Kaneko, T. Tanaka, H. Nakamura and N. Suganuma
丂 Ann Allergy Asthma Immunol. 2012 Feb;108(2): 117-122. (IF=2.801)

10) Asbestos-related diseases in Thailand and review literature.
丂 Subhannachart P, Dumavibhat N, Siriruttanapruk S.
丂 J Med Assoc Thai. 2012; 95(Suppl. 8): S71-6 (IF=No data)

11) Limonene inhalation reduces allergic airway inflammation in Dermatophagoides farinae-treated mice.
丂 Hirota R, Nakamura H, Bhatti SA, Ngatu NR, Muzembo BA, Dumavibhat N, Eitoku M, Sawamura M, Suganuma N.
丂 Inhal Toxicol. 2012 May;24(6):373-81. (IF=1.919)

12) Proficiency in reading pneumoconiosis radiographs examined by the 60-film set with 4-factor structuring 8-index.
丂 Zhou H, Kusaka Y, Tamura T, Suganuma N, Subhannachart P, Siriruttanapruk S, Dumavibhat N, Zhang X, Sishodiya
丂 PK, Van Duy K, Hering KG, Parker JE, Algranti E, Fedotov I, Shida H, Akira M.
丂 Ind Health. 2012;50(2):142-6. (IF=0.940)

13) The 60-film set with 8-index for examining physicians' proficiency in reading pneumoconiosis chest X-rays.
丂 Zhou H, Kusaka Y, Tamura T, Suganuma N, Subhannachart P, Siriruttanapruk S, Dumavibhat N, Zhang X, Sishodiya
丂 PK, Van Duy K, Hering KG, Parker JE, Algranti E, Fedotov I, Shida H, Akira M.
丂 Ind Health. 2012;50(2):84-94. Epub 2012 Feb 3. (IF=0.940)

14) ES cell differentiation system recapitulates the establishment of imprinted gene expression in a cell-type-specific
丂 manner.
丂 Kohama C, Kato H, Numata K, Hirose M, Takemasa T, Ogura A, Kiyosawa H.
丂 Hum Mol Genet. 2012 Mar 15;21(6):1391-401. (IF=7.636)

挊彂

1) Genome-wide analysis of sense-antisense transcripts, in 乬Non-coding RNAs and Epigenetic Regulation of Gene
丂 Expression: Drivers of Natural Selection乭
丂 (Morris KV ed.), Kohama C and Kiyosawa H,
丂 pp. 3-29, Caister Academic Press, Norwich, U.K., 2012.

庢摼

1)摿嫋4998954崋 傾儗儖僊乕敪徢梊杊梡僼傿儖僞乕偺奐敪
丂 搊榐擔:丂暯惉24擭5寧25擔

弌婅

1)PCT WO2012 042970 PCT/JP2011/061910丄傾僩僺乕惈旂晢墛偺梊杊嵻丄偍傛傃奜梡嵻
丂 峅揷検擇丒NGATU丂Roger (2012)丂弌婅擔2011擭5寧24擔

崙撪妛夛

1) 撿傑傝側丄悰徖惉暥
丂 偙偆偪僄僐僠儖挷嵏偺儕僋儖乕僩忬嫷
丂 戞俇俀夞崅抦嶻壢晈恖壢妛夛妛弍廤夛丄2012擭12寧8擔丄崅抦導

2) 撿傑傝側
丂 偙偆偪僄僐僠儖挷嵏偺儕僋儖乕僩忬嫷偲僼僅儘乕傾僢僾埬
丂 擔杮巕偳傕媠懸杊巭妛夛戞18夞妛弍廤夛丂崅抦傝傚偆傑戝夛丄2012擭12寧8擔丄 崅抦導

3) 撿傑傝側
丂 偙偆偪僄僐僠儖挷嵏偺儕僋儖乕僩忬嫷偲僼僅儘乕傾僢僾埬
丂 暯惉俀係擭搙崅抦導彫帣曐寬嫤夛妛夛丄2012擭8寧2擔丄崅抦導

4) 悰徖惉暥
丂 僄僐僠儖偵偮偄偰
丂 暯惉俀俁擭搙崅抦嶻壢晈恖壢妛夛媦傃崅抦導嶻晈恖壢堛夛掕椺憤夛丄2012擭5寧12擔丄崅抦導

5) 峅揷検擇
丂 僒僋儔儞偺椪彴墳梡偵偮偄偰
丂 僒僋儔儞尋媶夛乮僉僢僋僆僼儈乕僥傿儞僌乯丄2012擭1寧26擔亅27擔乮孎杮巗乯

6) 惔郪廏岴
丂 堚揱巕僪乕僺儞僌嵟慜慄 乣暘巕堚揱妛幰偑峫偊傞僸僩傊堚揱巕傪摫擖偡傞偙偲偺婋尟惈乣
丂 戞20夞擔杮塣摦惗棟妛夛僔儞億僕僂儉
丂 乽僪乕僺儞僌尋媶嵟慜慄丂敆傝偔傞婋婡偵尋媶幰偼偳偆棫偪岦偐偆偺偐丠廃曈尋媶椞堟偺愱栧壠偑傾僗儕乕僩偺僪乕僺儞僌偺崱偲
丂 崱屻傪峫偊傞乿丄偮偔偽丄2012擭7寧

1) 峅揷 検擇
丂 戞34夞乮岞嵿乯愇杮婰擮僨僒儞僩僗億乕僣壢妛怳嫽嵿抍尋媶彆惉嬥桪廏擖慖
丂 乽億儕僄僗僥儖壔慇傪尨場偲偡傞怴婯愙怗惈旂晢墛恌抐朄偺奐敪偲姵幰昿搙偺夘擖挷嵏乿 2012.

2) 媨揷擔岦巕丄戝恄埢巕丄媨栰埳抦榊丄戝塝杻奊丄埨揷惤巎
丂 乽抧堟崅楊幰偵偍偗傞庡娤揑寬峃娤偺梫場乿
丂 戞12夞 KMS儕僒乕僠儈乕僥傿儞僌彠椼徿. 2013.

丂 1) 偼偨傕乣傜乮暯惉24擭4寧崋宖嵹乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 2) 俶俫俲憤崌乽偙偆偪忣曬偄偪偽傫乿乮暯惉24擭4寧12擔曻憲乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 3) 俼俲俠崅抦曻憲僥儗價乽偙偆偪倕倷倕乿乮暯惉24擭4寧12擔曻憲乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 4) 俲倀俿倁僥儗價崅抦乽僀僽僯儞僌俲俷俠俫俬乿乮暯惉24擭4寧12擔曻憲乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 5) 俲俽俽偝傫偝傫僥儗價乽俽倀俶俽倀俶僗乕僷乕僯儏乕僗乿乮暯惉24擭4寧12擔曻憲乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 6) 崅抦怴暦乮暯惉24擭4寧13擔宖嵹乯 挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 7) 撉攧怴暦乮暯惉24擭4寧13擔宖嵹乯 挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 8) 枅擔怴暦乮暯惉24擭4寧13擔宖嵹乯 挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂 9) 俼俲俠崅抦曻憲儔僕僆乽媣曐揷僸儘僔偺婥暘偼忋乆乿乮暯惉24擭4寧16擔曻憲乯

丂10) 挬擔怴暦乮暯惉24擭4寧19擔宖嵹乯 挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂11) 俼俲俠崅抦曻憲僥儗價乽偛偒偘傫Bonito偭両乿乮暯惉24擭4寧21擔曻憲乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂12) 崅抦働乕僽儖僥儗價乽傒傫側偺峀応乿乮暯惉24擭4寧28擔~摨擭5寧4擔曻憲乯丂僄僐僠儖徯夘

丂13) 俲倀俿倁僥儗價崅抦乽儂僢僩崘抦斅乿乮暯惉24擭5寧3擔曻憲乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂14) 俲俽俽偝傫偝傫僥儗價乽偝傫偝傫PickUp乿乮暯惉24擭5寧7擔曻憲乯丂挷嵏抧嬫奼戝丒恖悢憹偵偮偄偰

丂15) 崅抦導嶻晈恖壢堛曬丂戞23崋乮暯惉24擭5寧12擔宖嵹乯戞俇侾夞崅抦嶻壢晈恖壢妛夛 妛弍島墘夛丒摿暿島墘梫巪

丂16) 峀曬丂偙偆側傫乮暯惉24擭6寧崋宖嵹乯 僄僐僠儖挷嵏偵偛嫤椡傪

丂17) 峀曬丂崄旤乮暯惉24擭6寧崋宖嵹乯丂僄僐僠儖挷嵏偵偛嫤椡傪

丂18) 峀曬丂偲偝偟傒偢乮暯惉24擭6寧崋宖嵹乯 僄僐僠儖挷嵏偵偛嫤椡傪

丂19) 峀曬丂偡偔傕乮暯惉24擭7寧崋宖嵹乯丂 僄僐僠儖徯夘

丂20) 峀曬丂備偡偼傜乮暯惉24擭7寧崋宖嵹乯丂僄僐僠儖徯夘忬嫷丄嶲壛幰僀儞僞價儏乕

丂21) 戝妛峀曬帍 俴倕倎倓 2012壞崋乮暯惉24擭7寧乯丂僄僐僠儖嶲壛屇傃偐偗

丂22) 偼偨傕乣傜乮暯惉24擭7寧崋宖嵹乯丂僄僐僠儖挷嵏徯夘丒抧堟僀儀儞僩嶲壛

丂23) 峀曬丂巐枩廫乮暯惉24擭8寧崋宖嵹乯丂僄僐僠儖徯夘

丂24) 峀曬丂側傫偙偔乮暯惉24擭8寧崋宖嵹乯丂 僄僐僠儖徯夘

丂25) 峀曬丂偁偐傞偄傑偪乮暯惉24擭8寧崋宖嵹乯僄僐僠儖徯夘

丂26) 俼俲俠崅抦曻憲僥儗價乽偙偆偪倕倷倕乿乮暯惉24擭9寧6擔曻憲乯 嶲壛幰3000恖偵

丂27) 崅抦怴暦乮暯惉24擭9寧7擔宖嵹乯丂嶲壛幰3000恖偵

丂28) 傎偭偲偙偆偪乽儅儅偺杮乿乮暯惉24擭9寧25擔敪攧乯僄僐僠儖徯夘

丂29) 崅抦働乕僽儖僥儗價乽傒傫側偺峀応乿乮暯惉24擭9寧1擔乣摨擭9寧7擔曻憲乯嶲壛幰3,000恖偵

丂30) 偼偨傕乣傜乮暯惉24擭10寧崋宖嵹乯 丂僄僐僠儖挷嵏徯夘丒抧堟僀儀儞僩嶲壛

丂31) 戝妛峀曬帍 俴倕倎倓 2012廐崋乮暯惉24擭10寧乯丂嶲壛幰3,000恖偵

丂32) 俲倀俿倁僥儗價崅抦乽僀僽僯儞僌俲俷俠俫俬乿乮暯惉24擭10寧5擔曻憲乯 嶲壛幰3,000恖偵

丂33) 崅抦働乕僽儖僥儗價乽傒傫側偺峀応乿乮暯惉24擭10寧13擔乣摨擭10寧19擔曻憲乯僀儀儞僩偍抦傜偣

丂34) 崄撿働乕僽儖僥儗價乽傜偔偄偔乿乮暯惉24擭10寧24擔乣摨擭10寧25擔曻憲乯 僄僐僠儖挷嵏徯夘

丂35) 俼俲俠崅抦曻憲儔僕僆乽婥偵側傞寬峃僼傽儈儕乕僪僋僞乕乿乮暯惉24擭10寧29擔曻憲乯僄僐僠儖挷嵏徯夘

丂36) 俼俲俠崅抦曻憲儔僕僆乽婥偵側傞寬峃僼傽儈儕乕僪僋僞乕乿乮暯惉24擭11寧13擔曻憲乯僄僐僠儖挷嵏徯夘乮嵞曻憲乯

丂37) 崄撿働乕僽儖僥儗價丂乽傜偔偄偔乿乮暯惉24擭11寧24擔曻憲乯丂僄僐僠儖挷嵏偵偮偄偰

丂38) 俶俫俲憤崌乽偙偆偪忣曬偄偪偽傫乿乮暯惉24擭12寧13擔曻憲乯丂倀俽俛儊儌儕暣幐偺偍榣傃偲曬崘

丂39) 俲俽俽偝傫偝傫僥儗價乽俽倀俶俽倀俶僗乕僷乕僯儏乕僗乿乮暯惉24擭12寧13擔曻憲乯倀俽俛儊儌儕暣幐偺偍榣傃偲曬崘

丂40) 俼俲俠崅抦曻憲僥儗價乽偙偆偪eye乿乮暯惉24擭12寧13擔曻憲乯倀俽俛儊儌儕暣幐偺偍榣傃偲曬崘

丂41) 崅抦怴暦乮暯惉24擭12寧14擔宖嵹乯丂倀俽俛儊儌儕暣幐偺偍榣傃偲曬崘

丂42) 挬擔怴暦乮暯惉24擭12寧14擔宖嵹乯丂倀俽俛儊儌儕暣幐偺偍榣傃偲曬崘

丂43) 撉攧怴暦乮暯惉24擭12寧14擔宖嵹乯丂倀俽俛儊儌儕暣幐偺偍榣傃偲曬崘

丂44) 枅擔怴暦乮暯惉24擭12寧14擔宖嵹乯丂倀俽俛儊儌儕暣幐偺偍榣傃偲曬崘

丂45) 偼偨傕乣傜乮暯惉25擭1寧崋宖嵹乯 丂丂僄僐僠儖挷嵏徯夘丒嬣夑怴擭

丂46) 偪傚傞傞傫News憂姧乮暯惉25擭2寧敪姧乯

丂47) 崅抦怴暦乮暯惉25擭2寧4擔宖嵹乯 丂丂挷嵏曬崘丒擠晈偺媔墝棪摍偵偮偄偰

丂48) 俼俲俠崅抦曻憲僥儗價乽偛偒偘傫Bonito偭両乿乮暯惉25擭2寧9擔曻憲乯嶲壛幰4,000恖払惉曬崘丄嶲壛幰偺惡

丂49) 俲倀俿倁僥儗價崅抦丂乽儂僢僩崘抦斅乿乮暯惉25擭2寧13擔曻憲乯嶲壛幰4,000恖払惉曬崘

丂50) 俲俽俽偝傫偝傫僥儗價丂乽偝傫偝傫PickUp乿乮暯惉25擭2寧22擔曻憲乯嶲壛幰4,000恖払惉曬崘

丂51) 傎偭偲偙偆偪乽崅抦昦堾僈僀僪乿乮暯惉25擭2寧25擔敪攧乯丂僄僐僠儖挷嵏徯夘

丂52) 枅擔怴暦乮暯惉25擭3寧20擔宖嵹乯丂巐崙寬峃僫價

偦偺懠

亂崙嵺楢実亃
丂丂侾乯2013擭3寧18擔
丂丂僋儕僗僩僼傽乕丒僊儖僶乕僌攷巑偵傛傞僌儔僂儞僪儔僂儞僪
丂 亀僐儂乕僩尋媶偵偍偗傞乬ESSENCE乭 丂-彫帣恄宱敪払忈奞偺憗婜儅乕僇乕偵偮偄偰亁
丂丂悰徖惉暥丄埨岝儔償僃儖崄曐巕

亂嶻妛楢実亃
丂丂侾乯怉暔桼棃偺傾僩僺乕惈旂晢墛帯椕栻丄 峅揷検擇
丂丂幘姵暿彜択夛乮傾儗儖僊乕丒柶塽丒墛徢幘姵椞堟乯2012擭2寧1擔乮戝嶃乯
丂丂俀乯Vernonia amygdalina (VAM) 僄僉僗偺傕偮丄峈傾儗儖僊乕丄峈偐備傒岠壥
丂丂Anti-inflammatory, Anti-itch Activity, and Therapeutic Effects of Extracts of Vernonia Amygdalina leaves in NC / Nga
丂丂Mice induced Atopic Dermatitis.
丂丂峅揷検擇
丂丂戞3夞丂崙嵺壔徬昳奐敪揥-Cosme Tech 2012- 傾僇僨儈僢僋僼僅乕儔儉
丂丂2012擭6寧27擔(悈)乣29擔(嬥)丂搶嫗價僢僌僒僀僩乮搶嫗乯
丂丂俁乯墿嵒偑傕偨傜偡傾儗儖僊乕偺梊杊僼傿儖僞乕偺奐敪丄峅揷検擇丒拞懞桾擵
丂丂戝妛摍媄弍僔乕僘宆尋媶夛丄 暯惉俀係擭侾侾寧俈擔乮巐崙拞墰巗乯

亂僙儈僫乕丒島墘摍亃
丂1) 惔郪廏岴
丂丂 歁擕摦暔僎僲儉偺揮幨妶摦乣旕僐乕僪丒傾儞僠僙儞僗揮幨傪椺偵偲偭偰乣
丂丂 崅抦岺壢戝妛島墘夛乽尰戙壢妛偺嵟愭抂乿丄崅抦丄2012擭7寧
丂2) 惔郪廏岴
丂丂 ES嵶朎偺in vitro暘壔宯傪梡偄偨婡擻惈傾儞僠僙儞僗RNA夝愅
丂丂 嶉嬍堛壢戝妛僎僲儉壢妛尋媶僙儞僞乕塣塩埾堳夛彸擣妛弍廤夛丄擔崅乮嶉嬍導乯丄2013擭3寧

1) Indocyanine green angiography for intra-operative assessment in vascular surgery.
丂 Yamamoto M, Orihashi K, Nishimori H, Wariishi S, Fukutomi T, Kondo N, Kihara K, Sato T, Sasaguri S.
丂 Eur J Vasc Endovasc Surg. 2012 Apr; 43(4): 426-32.乮IF: 2.991乯

2) Indocyanine green injection for detecting sentinel nodes using color fluorescence camera in the laparoscopy-assisted
丂 gastrectomy.
丂 Yoshida M, Kubota K, Kuroda J, Ohta K, Nakamura T, Saito J, Kobayashi M, Sato T, Beck Y, Kitagawa Y, Kitajima M.
丂 J Gastroenterol Hepatol. 2012 Apr; 27 Suppl 3: 29-33. (IF: 2.865)

3) Influences of donepezil on cardiovascular system--possible therapeutic benefits for heart failure--donepezil cardiac
丂 test registry (DOCTER) study.
丂 Kubo T, Sato T, Noguchi T, Kitaoka H, Yamasaki F, Kamimura N, Shimodera S, Iiyama T, Kumagai N, Kakinuma Y,
丂 Diedrich A, Jordan J, Robertson D, Doi YL.
丂 J Cardiovasc Pharmacol. 2012 Sep; 60(3): 310-4. (IF: 2.287)

4) Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension.
丂 Shimizu Y, Yamasaki F, Furuno T, Kubo T, Sato T, Doi Y, Sugiura T.
丂 Int J Gen Med. 2012; 5: 753-8. Epub 2012 Sep 10. (IF: No data)

5) A non-neuronal cardiac cholinergic system plays a protective role in myocardium salvage during ischemic insults.
丂 Kakinuma Y, Akiyama T, Okazaki K, Arikawa M, Noguchi T, Sato T.
丂 PLoS One. 2012; 7(11): e50761. Epub 2012 Nov 29. (IF: 4.092)

6) Nociceptive sensory innnervation of the posterior cruciate ligament in osteoarthritic knees.
丂 Ikeuchi M, Wang Q, Izumi M, Tani T.
丂 Arch. Orthop. Trauma Surg. 2012 Jun;132(6):891-5. (IF: 1.369)

7) Maximum voluntary ventilation as a sensitive measure to monitor the ventilatory function in cervical spondylotic
丂 myelopathy.
丂 Nomura T, Tani T, Ikeuchi M, Akutagawa T, Enoki H, Ishida K.
丂 Spinal Cord. 2012 Apr;50(4):328-332. (IF: 1.805)

8) Nonlinear adaptive controller for omni-directional walker: dynamic model improvement and experiment.
丂 Tan R, Wang S, Jiang Y, Ishida K, Fujie MG.
丂 ICIC Express Letters. 2012 Mar;6(3):611-15.

9) User control intention recognition of an omnidirectional walking support walker: considering both directional and
丂 rotational intentions.
丂 Jiang Y, Wang S, Tan R, Ishida K, Ando T, Fujie MG.
丂 ICIC Express Letters. 2012 Feb;6(2):479-84.

10)Motion control for an intelligent walking support machine.
丂 Wang Y, Wang S, Tan R, Jiang Y, Ishida K, Fujie MG.
丂 ICIC Express Letters. 2012 Jan;6(1):145-49.

挊彂

1) Sato T, Diedrich A, Sunagawa K.
丂 Bionic Baroreflex.
丂 PRIMER ON THE AUTONOMIC NERVOUS SYSTEM. THIRD EDITION(Robertson D et al. editors.) p.659-662.
丂 ELSEVIER, 2012

1) 摿嫋戞4971816崋乽嶣憸憰抲乿敪柧幰丗扟杮岶巌丄 嵅摗棽岾
丂 庢摼擔丗2012.04.13

2) 摿嫋戞5127003崋丄慡曽岦堏摦婡擻傪帩偮曕峴孭楙婍丄暷戲愖嬍丒愇揷寬巌
丂 搊榐擔丂2012.11.09

弌婅

1) 崙撪弌婅丂3審(旕岞奐)丂 嵅摗棽岾

崙撪妛夛

1) Kakinuma Y, Akiyama T, Arikawa M, Sato T.
丂 Cholinoceptive cholinergic properties of cardiomyocytes: Amplification mechanism for vagal efferent effects.
丂戞76夞擔杮弞娐婍妛夛妛弍廤夛 2012.3.16-18 暉壀巗

2) 嵅摗棽岾
丂 妛栤傪挻偊偰偄偞幚慔乮愴乯丗慜恑偁傞偺傒
丂 戞21夞擔杮僐儞僺儏乕僞奜壢妛夛戝夛丄戞4夞擔杮堛岺傕偺偮偔傝僐儌儞僘丒僔儞億僕僂儉丂 2012.11.2-4丂 摽搰巗

3) 嵅摗棽岾
丂 拲幩偺擸傒夝寛偟傑偡丗嬤愒奜寀岝僀儞僾儔儞僩偺壜擻惈
丂 崙嵺夋憸婡婍揥2012丂2012.12.5-7丂墶昹巗

1) 嵅摗棽岾
丂丂丂丂丂丂丂
丂 崙嵺夋憸婡婍揥2012丂擔杮塮憸張棟尋媶夛徿 丂
丂 尋媶壽戣丗拲幩偺擸傒夝寛偟傑偡丗嬤愒奜寀岝僀儞僾儔儞僩偺壜擻惈 丂丂丂丂丂丂丂
丂 庴徿擭寧丗2012.12.5

2) 愇揷寬巌
丂丂丂丂丂丂丂
丂 SCIS-ISIS 2012丂Best Application Award 丂
丂 乬User directional intention identification for a walking support walker -- adaptation to individual丂differences with
丂 fuzzy learning乭

曬摴

1) 僥儗價搶嫗乽儚乕儖僪價僕僱僗僒僥儔僀僩乿偵偍偄偰丄杮妛偑奐敪偟偨HyperEye Medical System傪梡偄偨擕娻僙儞僠僱儖儕儞
丂 僷愡庤弍偵娭偡傞嵟怴偺忣曬偲弍拞嶣塭偑徯夘偝傟偨丅2012.9.28曻憲丂嵅摗棽岾 丂丂

偦偺懠

亂憤愢亃
丂1) 嬤愒奜寀岝僇儔乕僀儊乕僕儞僌僔僗僥儉偺惢昳壔帠椺
丂丂 嵅摗棽岾
丂丂 堛椕婡婍妛 2012; 82(6): 463-467. (2012.12.1敪峴)
丂2) 帺棩恄宱幐挷徢偵偍偗傞婲棫惈掅寣埑
丂丂 嵅摗棽岾
丂丂 堛妛偺偁備傒 2012; 243(5): 433-438. 乮2012.11.3敪峴)

亂嶨帍亃
丂1) 堛椕傪巟偊傞傕偺偯偔傝僯僢億儞乽嬤愒奜寀岝僇儔乕僇儊儔僔僗僥儉乿
丂丂 嵅摗棽岾
丂丂 儊僨傿僇儖挬擔2012; 41: 68-71 乮2012.6.1敪峴乯
丂2) 媄弍偼偁偭偰傕惉挿巗応偵攚傪岦偗傞
丂丂 嵅摗棽岾
丂丂 廡娫僄僐僲儈僗僩倫39 乮2012.5.29敪峴乯 丂
丂

1) The influence of Goishi tea on adipocytokines in obese mice.
丂 Junko Yokota, Kohei Jobu, Saburo Yoshioka, Takehiro Kashiwagi, Tomoko Shimamura, Hironori Moriyama, Shuzo
丂 Murata, Masao Ohishi, Hiroyuki Ukeda, Mitsuhiko Miyamura.
丂 Food Chemistry. 2012,138(4), 2210-2218.(IF 3.655)

2) Anti-Allergic Effects of Vernonia amygdalina Leaf Extracts in Hapten-Induced Atopic Dermatitis-Like Disease in Mice.
丂 Nlandu Ngatu, Makiko K Okajima, Maki Yokogawa, Ryoji Hirota, Mikiro Takaishi, Masamitsu Eitoku, Basilua Andre
丂 Muzembo, Asif Bhatti Sabah, Takao Saruta, Mitsuhiko Miyamura, Tatsuo Kaneko, Narufumi Suganuma
丂 Allergology International. 2012,61(4), 597-607.( IF 0.759)

挊彂

1) 媨懞 廩旻(壀栰慞楴)
丂 堛栻昳忣曬妛乗婎慴偐傜椪彴傊乗堛椕尰応偵偍偗傞堛椕忣曬娗棟
丂 219-227丄淎愳彂揦丄搶嫗丄2012

1) 摿婅2012-231189丄殝壓婡擻夵慞嵻
丂 媨懞廩旻丄2012擭10寧18擔

崙嵺妛夛

1) 媨懞廩旻
丂 Higher education of pharmacy and drug therapy
丂 壚栘巣戝妛栻妛堾妛弍島墘夛丄2012擭7寧17擔丄崟棿峕徣壚栘巣巗丄拞崙

曬摴

媨懞廩旻

1) 戝妛昦堾帯尡僙儞僞乕偺尰忬偲栻妛惗偵寽偗傞婜懸
丂 暯惉24擭搙丂擔杮栻妛夛儂乕儉儁乕僕丂僩僺僢僋僗宖嵹

2) 崅抦戝妛堛妛晹偲摽搰暥棟戝妛栻妛晹乽栻妛嫵堢丒尋媶偺楢実偲嫤椡偵娭偡傞 嫤掕乿偺掲寢偵偮偄偰
丂 暯惉24擭8寧6擔乣7擔丗曬摴奺幮

3) 嵭奞帪偺栻偺旛偊屇傃偐偗傞嶜巕偺敪峴偵偮偄偰
丂 暯惉24擭8寧29擔:NHK